Researchers found that the previous assumption that a greater diversity of tumor cells was present in more aggressive tumors was false

Study finds 21-gene assay was associated with savings of approximately $3,600 per patient in chemotherapy costs alone for people with high-risk breast cancer

De-escalation of treatment strategies aims to minimize toxicity while maintaining efficacy

Compared to women ages 40 to 44 at average risk, incidence screening of women in their 30s with at least one of the three evaluated risk factors showed similar cancer detection rates

Adaptive design offers benefits over randomized controlled trials

New treatment option for patients who no longer respond to hormone therapy

Breast density can mask cancers on mammography and is an independent risk factor for the disease

Case Western Reserve researchers uncover novel drug targets by piecing together receptor structures